Why Did ABCL, REPL, ABNB Stocks Hit 52-Week Highs Today?
AbCellera, Replimune and Airbnb reached fresh highs as strong drug data, new funding and better-than-expected earnings boosted investor confidence. AbCellera stock hit a three-year high after positive Phase 2 results for ABCL635 showed an 83% reduction in hot-flash frequency. Replimune stock rallied after a $150 million financing to support TUDRIQEV’s launch. BMO Capital lifted Airbnb’s … Read more